-
29-03-2020, 08:08 AM
#6261
Blis is proven to work, they should be supplying information to the journalist.
-
29-03-2020, 09:20 AM
#6262
Originally Posted by Arthur
Blis is proven to work, they should be supplying information to the journalist.
Interesting. Can you cite evidence?
-
29-03-2020, 10:21 AM
#6263
Member
Originally Posted by fungus pudding
Interesting. Can you cite evidence?
As is often the case the evidence is ones experience. In our 80s we started taking Blis 8 years ago after a lot of reading and have been remarkably free of colds and flu compared to our friends. Even became shareholders and gave trial supplies to family.
Pat
Prediction is hard even with the crystal ball.
-
29-03-2020, 10:25 AM
#6264
Originally Posted by patrick
As is often the case the evidence is ones experience. In our 80s we started taking Blis 8 years ago after a lot of reading and have been remarkably free of colds and flu compared to our friends. Even became shareholders and gave trial supplies to family.
'Evidence of one's experience' is not proof. What is the proof that you say should be given to journalists?
-
29-03-2020, 10:51 AM
#6265
Member
What about the blind man in Bethsaida
“Then his eyes were opened and he saw everything clearly”
His experience was proof to him.....he could see.
Pat
Prediction is hard even with the crystal ball.
-
29-03-2020, 11:06 AM
#6266
Originally Posted by patrick
What about the blind man in Bethsaida
“Then his eyes were opened and he saw everything clearly”
His experience was proof to him.....he could see.
I am asking about a scientific matter in an enlightened age.
-
29-03-2020, 12:29 PM
#6267
I understand that there have been several clinical trials. You could have a look at these two for a start.
1. Di Pierro F1, Colombo M2, Zanvit A3, Rottoli AS4. Positive clinical
outcomes derived from using Streptococcus salivarius K12 to prevent
streptococcal pharyngotonsillitis in children: a pilot investigation. Drug
Healthc Patient Saf. 2016 Nov 21;8:77-81. eCollection 2016.
2. F. Di Pierro, M. Colombo, M.G. Giuliani, M.L. Danza, I. Basile, T.
Bollani, A.M. Conti, A. Zanvit, A.S. Rottoli. Effect of administration of
Streptococcus salivarius K12 on the occurrence of streptococcal
pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old
children. Eur Rev Med Pharmacol Sci Year: 2016 Vol. 20 - N. 21 Pages:
4601-4606.
-
29-03-2020, 12:29 PM
#6268
Member
Below is a link to an Independent Research Report from 2016, this looks like the easiest one place to start looking for information on clinical studies etc.
https://www.nzx.com/announcements/287583
There are several other announcements on studies in Italy and China.
-
29-03-2020, 12:55 PM
#6269
Member
Blis Manufacturing - as at Aug 2016
After sending out the link above, I have had a refresher / read and found this interesting information on manufacturing. This is good information considering the recent announcement on the 16th March.
“To date our supply chain, from ingredient supply through to manufacture of finished product has been able to meet the lift in demand and we have significantly increased our production to meet anticipated forward orders. We continue to monitor our supply chain for any future constraints.”
Blis Manufacturing (as at Aug 2016)
Prior to the commissioning of the Birch St facility in Dunedin in September 2013 at a cost of around $0.5m, Blis outsourced lozenge manufacturing to two offshore companies and one based in Nelson. On commissioning of the facility in Dunedin Blis has the capability to produce finished goods including lozenges (bottles and blisters), powders (bottles and sachets) and nutritionals (blended powders in bags and sachets and pre-mix for cans).
The basic ingredient is manufactured by Fonterra (Palmerston North) and shipped to Dunedin with logistics coordinated in Dunedin. The company has plenty of capacity at its Birch street facility to enable future growth.
Current manufacturing in Dunedin is on a single shift only with the ability to triple shift as and when required. Beyond this internal capacity, the company has offshore Lozenge contract manufacturers in Italy and Serbia servicing the EU and several contract manufacturers in the USA.
Blis also contract manufactures for a number of companies with dairy offerings as it holds a Ministry for Primary Industries (MPI) approved registered risk management programme (RMP) status for dairy manufacture. It also manufactures a small number of non-dairy products that require dry blending capability. The company sees the capability as useful as it provides a channel to market for Blis containing nutritional offers in the future.
We understand there has been some risk around raw material supply but the company is in the process of signing a revised supply agreement with Fonterra which will provide capacity to meet near term projections with Fonterra going through an internal process which if approved will serve to increase capacity available to Blis and meet Fonterra’s own needs. Further the company recognizes its single supplier risk and is evaluating alternate sources of supply both in the USA and Europe.
-
29-03-2020, 05:53 PM
#6270
Originally Posted by patrick
What about the blind man in Bethsaida
“Then his eyes were opened and he saw everything clearly”
His experience was proof to him.....he could see.
Just leave fp when it comes to BLT evidence as he had questioning those studies since I can remember
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks